JPRN-UMIN000003237
Completed
Phase 3
A phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical stage II/III squamous cell carcinoma of the anal canal (JCOG0903, SMART-AC) - A phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical stage II/III squamous cell carcinoma of the anal canal (JCOG0903, SMART-AC)
Japan Clinical Oncology Group(JCOG)0 sites71 target enrollmentFebruary 23, 2010
Conditionsanal canal caner
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- anal canal caner
- Sponsor
- Japan Clinical Oncology Group(JCOG)
- Enrollment
- 71
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Simultaneous or metachronous (within 5 years) double cancers , with the exception of intramucosal tumor curable with local therapy 2\) Patients requiring the administration of phenytoin or warfarin potassium 3\) Pregnant or lactating women or women of childbearing potential 4\) Psychosis 5\) Patients requiring systemic steroids medication 6\) Serum HBs antigen positive 7\) Anti\-HIV antibody positive 8\) Uncontrollable diabetes mellitus or administration of insulin. 9\) Uncontrollable hypertention 10\) Unstable angina, heart failure, or with a history of myocardial infarction within 6 months. 11\) Interstitial pneumonia, fibroid lung, or severe emphysema 12\) Active bacterial or fungous infection 13\) fever over 38 degrees centigrade
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophaguscervical esophageal cancerJPRN-UMIN000001439ational Cancer Center Hospital32
Completed
Phase 1
Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604)JPRN-jRCT2091220010Japan Clinical Oncology Group(JCOG)81
Unknown
Phase 1
Phase I/II Study of Satraplatin Plus RadiotherapyJPRN-jRCT2080221482Yakult Honsha Co.,Ltd.33
Not Yet Recruiting
Phase 1
Phase I study of concurrent chemoradiotherapy with docetaxel,cisplatin and 5-fluorouracil (DCF) in patients with locally advanced cancer of the external auditory canal and middle ear.eoplasm of the external auditory canal and middle earJPRN-UMIN000013304Kobe University Hospital12
Completed
Phase 2
Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01)terine cervical carcinomaJPRN-UMIN000002937Japanese Cancer Clinical Research Organization(JACCRO)70